Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.57
+0.09 (1.20%)
Jun 4, 2025, 1:56 PM - Market open
Ginkgo Bioworks Holdings Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Ginkgo Bioworks Holdings stock ranges from a low of $7.00 to a high of $12. The average analyst price target of $9.67 forecasts a 27.74% increase in the stock price over the next year.
Price Target: $9.67 (+27.74%)
Analyst Consensus: Sell
* Price targets were last updated on Sep 20, 2024.
Analyst Ratings
The average analyst rating for Ginkgo Bioworks Holdings stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 7 | 7 | 7 | 7 | 7 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $3 → $10 | Strong Buy | Maintains | $3 → $10 | +32.10% | Sep 20, 2024 |
| BTIG | BTIG | Strong Sell Maintains $0.2 → $7 | Strong Sell | Maintains | $0.2 → $7 | -7.53% | Aug 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $12 | Strong Sell | Maintains | $32 → $12 | +58.52% | Jul 9, 2024 |
| BTIG | BTIG | Strong Sell Maintains $20 → $8 | Strong Sell | Maintains | $20 → $8 | +5.68% | Jun 26, 2024 |
| BTIG | BTIG | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | May 15, 2024 |
Financial Forecast
Revenue This Year
179.34M
from 227.04M
Decreased by -21.01%
Revenue Next Year
206.71M
from 179.34M
Increased by 15.26%
EPS This Year
-6.42
from -10.54
EPS Next Year
-4.55
from -6.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 188.9M | 262.5M | 188.2M |
| Avg | 179.3M | 206.7M | 181.0M |
| Low | 168.0M | 168.1M | 175.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -16.8% | 46.4% | -9.0% |
| Avg | -21.0% | 15.3% | -12.4% |
| Low | -26.0% | -6.3% | -15.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.16 | -3.98 | -3.40 |
| Avg | -6.42 | -4.55 | -3.27 |
| Low | -7.13 | -5.04 | -3.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.